4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-034601
Chief Business Officer sold 42,865 shares at an average $8.73 ($374,034)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Virani Shafique · Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-01 | Sale : show line 1 in the form 10b5-1 | −25,000 | $8.58 | $214,500 | 161,819 | D |
| 2023-06-02 | Sale : show line 2 in the form 10b5-1 | −17,865 | $8.93 | $159,534 | 143,954 | D |
| Open-market sales · 42,865 sh · avg $8.73 · $374,034 | ||||||
Loading xslF345X04/doc4.xml…